ArticleJournal of personalized medicine2024

Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis.

Francisco J Barrero Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.